Studies Addressing Rare Neurodegenerative Diseases including ALS
Forecast
Food and Drug Administration plans to offer grants to any type of organization. It expects to make about 10 awards. It is a forecast, and no dates have been set yet.
From the official notice on Grants.gov, last changed August 15, 2024. Checked October 31, 2026.
- Award ceilingnot stated
- Award floornot stated
- Expected awards10
- Total fundingnot stated
- Cost sharingNot required
- Funding typeGrant
Key dates
| Forecast posted | August 14, 2024 |
|---|
Who can apply
This opportunity is open to any type of organization.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Terrin Brown, Grantor, terrin.brown@fda.hhs.gov, 2404027610.
Questions people ask
Who can apply for Studies Addressing Rare Neurodegenerative Diseases including ALS?
Food and Drug Administration accepts applications from any type of organization.
What is the deadline for Studies Addressing Rare Neurodegenerative Diseases including ALS?
Forecast, no dates yet. Confirm the date and time in the official notice on Grants.gov.
Similar open grants
- Tribal Colleges Extension Program Special Emphasis
- Emergency Citrus Disease Research and Extension Pre-Applications
- 1890 Institution Teaching, Research, and Extension Capacity Building Grants Program
- Capacity Building Grants for Non-Land-Grant Colleges of Agriculture Program
- FY26 US DOT Drone Infrastructure Inspection Grants (DIIG) Program
- Small Business Innovation Research and Small Business Technology Transfer Programs Phase II